These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2803952)

  • 1. First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
    Athanassiou AE; Bafaloukos D; Pectasides D; Dimitriadis M; Varthalitis I; Barbounis V
    Br J Cancer; 1989 Nov; 60(5):755-8. PubMed ID: 2803952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin plus VP 16-213 in advanced ovarian carcinoma.
    Harnett PR; Bell DR; Hillcoat BL; Woods RL; Levi JA; Rome RM; Campbell JC; Tattersall MH
    Gynecol Oncol; 1988 Jun; 30(2):159-62. PubMed ID: 3371739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B; Hansen OP; Hansen HH; Hansen M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer.
    Chambers SK; Chambers JT; Kohorn EI; Schwartz PE
    Gynecol Oncol; 1987 Jun; 27(2):233-40. PubMed ID: 3570062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
    Reichman B; Markman M; Hakes T; Hoskins W; Rubin S; Jones W; Almadrones L; Ochoa M; Chapman D; Saigo P
    J Clin Oncol; 1989 Sep; 7(9):1327-32. PubMed ID: 2671288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
    Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma.
    De Lena M; Lorusso V; Romito S
    Cancer Treat Rep; 1986 Jul; 70(7):893-5. PubMed ID: 3719581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1995; 16(1):12-7. PubMed ID: 7744111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas.
    Tropé C; Kaern J; Vergote I; Vossli S
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S45-7. PubMed ID: 2347051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
    Wilke H; Preusser P; Fink U; Gunzer U; Meyer HJ; Meyer J; Siewert JR; Achterrath W; Lenaz L; Knipp H
    J Clin Oncol; 1989 Sep; 7(9):1318-26. PubMed ID: 2769330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
    Howell SB; Kirmani S; Lucas WE; Zimm S; Goel R; Kim S; Horton MC; McVey L; Morris J; Weiss RJ
    J Clin Oncol; 1990 Jan; 8(1):137-45. PubMed ID: 2295904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.
    Lévi F; Benavides M; Chevelle C; Le Saunier F; Bailleul F; Misset JL; Regensberg C; Vannetzel JM; Reinberg A; Mathé G
    J Clin Oncol; 1990 Apr; 8(4):705-14. PubMed ID: 2179481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H; Rasmussen S; Simonsen E
    Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
    Markman M; Blessing JA; Major F; Manetta A
    Gynecol Oncol; 1993 Aug; 50(2):191-5. PubMed ID: 8375734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin plus VP16-213 in refractory ovarian carcinoma.
    Lele SB; Piver MS; Malfetano J
    Am J Clin Oncol; 1987 Feb; 10(1):21-2. PubMed ID: 3825989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer.
    Di Re F; Bohm S; Oriana S; Spatti GB; Zunino F
    Cancer Chemother Pharmacol; 1990; 25(5):355-60. PubMed ID: 2306797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
    Willemse PH; Sleijfer DT; de Vries EG; Boonstra H; Bouma J; Mulder NH
    Eur J Cancer; 1992; 28(2-3):479-81. PubMed ID: 1591067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide and etoposide salvage treatment in advanced ovarian cancer.
    Bruzzone M; Campora E; Merlini L; Giudici S; Bottero G; Iskra L; Donadio M; Ferrari I; Ragni N
    J Chemother; 1991 Oct; 3(5):332-4. PubMed ID: 1809812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.